To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat <font color="red">patients_1</font> <font color="red">with_1</font> <font color="red">primary_2</font> <font color="red">Raynaud_2</font> <font color="red">'s_2</font> <font color="red">phenomenon_2</font> <font color="red">in_2</font> <font color="red">South_2</font> <font color="red">Korea_2</font> <font color="red">;_2</font> Korean Raynaud study ( KOARA study ) . 
<br>
<br> This study examined the efficacy and safety of nifedipine sustained release ( nifedipine SR ) compared with Ginkgo biloba extract as treatment for <font color="red">primary_2</font> <font color="red">Raynaud_2</font> <font color="red">'s_2</font> <font color="red">phenomenon_2</font> <font color="red">(_2</font> <font color="red">RP_2</font> <font color="red">)_2</font> <font color="red">in_2</font> <font color="red">Korea_2</font> <font color="red">._2</font> <font color="red">Primary_1</font> <font color="red">RP_1</font> were screened and assigned to either the nifedipine SR group ( Group N ) or the Ginkgo biloba extract group ( Group G ) in the ratio of 2:1 . After a run - in period of 2 weeks , patients received treatment for 8 weeks . We observed the percent improvement of the RP attack rate between before and after the 8-week treatment . <font color="red">Ninety_1</font> <font color="red">-_1</font> <font color="red">three_1</font> <font color="red">subjects_1</font> <font color="red">were_1</font> <font color="red">randomly_1</font> <font color="red">assigned_1</font> <font color="red">._1</font> The percent improvement in Group N was 50.1% at 8 weeks after treatment , while it was 31.0% in Group G ( p = 0.03 ) . No serious adverse events occurred , and almost adverse events were mild and improved without specific treatment . nifedipine SR was more effective than Ginkgo biloba extract for treatment of <font color="red">primary_2</font> <font color="red">RP_2</font> <font color="red">in_2</font> <font color="red">Korean_2</font> <font color="red">patients_2</font> <font color="red">._2</font> Both drugs were tolerable with <font color="red">primary_2</font> <font color="red">RP_2</font> <font color="red">patients_2</font> <font color="red">._2</font>